7 Aralık 2019 Cumartesi

Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay?


By BY GINA KOLATA from NYT Health Adakveo and Oxbryta could be revolutionary treatments, but each costs about $100,000 per year and must be taken for life. https://ift.tt/3520H25

Hiç yorum yok:

Yorum Gönder

Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic

By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...